[H2-blockers of histamine receptors in the therapy of early stages of gastroduodenal reflux disease].
The efficacy of the administration of famotidine, 20 mg BID, at early stages of gastroduodenal reflux disease (GDRD) based on a clinical and endoscopy study and treatment of patients of 0 and 1 degrees on the modified Savary-Miller scale.
Lazebnik
L B
LB
Vasil'ev
Iu V
IuV
Masharova
A A
AA
Zelenkin
S A
SA
Ianova
O B
OB
D000293:Adolescent; D000328:Adult; D000368:Aged; D004383:Duodenogastric Reflux / Q000175:diagnosis / Q000188:drug therapy*; D016099:Endoscopy, Gastrointestinal; D015738:Famotidine / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D006635:Histamine H2 Antagonists; D015738:Famotidine